| Overview |
| bsm-52053r-fitc-100ul |
| Cytokeratin 13 Recombinant Antibody, FITC Conjugated |
| WB, IF |
| Human, Mouse |
| Specifications |
| FITC |
| Rabbit |
| A synthesized peptide derived from human Cytokeratin 13 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3861 |
| P02533 |
| Cytoplasm, Nucleus |
| type I cytoskeletal 13; 47 kDa cytokeratin; CK-13; CK13; Cytokeratin-13; K13; K1C13_HUMAN; Ka13; Keratin 13; Keratin; keratin type I cytoskeletal 13; Keratin-13; Krt-1.13; Krt1-13; KRT13; MGC161462; MGC3781; Type I keratin Ka13; Keratin, type I cytoskeletal 13; K13. |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
|
Powered by Bioz